The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Afatinib in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) harboring alterations in the HER pathway: Results of the B1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).
 
Rachel Galot
Travel, Accommodations, Expenses - Merck
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Novartis; Rakuten Medical; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD
 
Lisa F. Licitra
Consulting or Advisory Role - ACC Med+Logistics; Adlai Nortye; AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Debiopharm Group; Eisai; Exelixis; GlaxoSmithKline; IRX Therapeutics; Medpace; Merck Serono; MSD; Neutron Therapeutics; Novartis; Pfizer; Roche; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
 
Amaury Daste
Consulting or Advisory Role - BMS; Merck; MSD
Travel, Accommodations, Expenses - BMS; Merck
 
Caroline Even
Consulting or Advisory Role - Bristol-Myers Squibb; Fstar Therapeutics (Inst); Innate Pharma; Merck Serono; MSD Oncology; Novartis (Inst)
Travel, Accommodations, Expenses - Merck Serono; Merck Serono; MSD Oncology
 
Esma Saada-Bouzid
No Relationships to Disclose
 
Stephanie Henry
Consulting or Advisory Role - AstraZeneca; BMSi; Gilead Sciences; GlaxoSmithKline; Merck; MSD Oncology; Novartis; Sanofi
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD Oncology; Roche
 
Sylvie Rottey
Consulting or Advisory Role - BMS GmbH & Co. KG (Inst); ipsen (Inst); Janssen (Inst); MSD (Inst); Pfizer (Inst)
Speakers' Bureau - BMS GmbH & Co. KG (Inst); BMS GmbH & Co. KG (Inst); ipsen (Inst); Roche (Inst)
Research Funding - BMS GmbH & Co. KG (Inst)
Travel, Accommodations, Expenses - Merck (Inst); MSD (Inst)
 
Emmanuel Seront
No Relationships to Disclose
 
Marie-Christine Kaminsky
No Relationships to Disclose
 
Sylvie Zanetta
Travel, Accommodations, Expenses - MSD Oncology
 
Annemie Rutten
No Relationships to Disclose
 
Neus Baste
Consulting or Advisory Role - Amgen; Bayer; BioNTech; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Merck Serono; Merck Serono; MSD Oncology; Novartis; Roche; Roche
Research Funding - Merck Serono
 
Philip R. Debruyne
Stock and Other Ownership Interests - Alkermes; Biocartis
Honoraria - Bayer; Bristol-Myers Squibb; Ipsen; Merck/Pfizer
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Janssen
 
Jérémy Leys
No Relationships to Disclose
 
Konstantina Tsechilidou
No Relationships to Disclose
 
Catherine Fortpied
No Relationships to Disclose
 
Sandrine Marreaud
No Relationships to Disclose
 
Anne-Sophie Govaerts
No Relationships to Disclose
 
Jean-Pascal H. Machiels
Consulting or Advisory Role - ALX Oncology; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; CUE Biopharma; eTHERNA; F-star; Incyte; Innate Pharma; ITeos Therapeutics; Janssen; Merck Serono; Merck Sharp & Dohme; NEKTAR; Novartis; Pfizer; Roche
Research Funding - Bayer; Janssen; Novartis; Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Gilead Sciences; MSD; Pfizer
Other Relationship - PsiOxus Therapeutics